Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial
CONCLUSIONS: Early intravitreal TA injection for OGI effectively reduces TPVR, increases surgical success and improves visual prognosis.PMID:38041678 | DOI:10.1136/bjo-2023-324318 (Source: The British Journal of Ophthalmology)
Source: The British Journal of Ophthalmology - December 2, 2023 Category: Opthalmology Authors: Haixia Guo Jinguo Yu Tiangeng He Song Chen Zhuoyu Sun Jingkai Zhang Zhiyong Sun Wenhui Yang Baoqun Yao Xueli Yang Yuanyuan Liu Mingxue Zhang Yu Meng Likun Yang Hua Yan Source Type: research

Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial
CONCLUSIONS: Early intravitreal TA injection for OGI effectively reduces TPVR, increases surgical success and improves visual prognosis.PMID:38041678 | DOI:10.1136/bjo-2023-324318 (Source: The British Journal of Ophthalmology)
Source: The British Journal of Ophthalmology - December 2, 2023 Category: Opthalmology Authors: Haixia Guo Jinguo Yu Tiangeng He Song Chen Zhuoyu Sun Jingkai Zhang Zhiyong Sun Wenhui Yang Baoqun Yao Xueli Yang Yuanyuan Liu Mingxue Zhang Yu Meng Likun Yang Hua Yan Source Type: research

Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial
CONCLUSIONS: Early intravitreal TA injection for OGI effectively reduces TPVR, increases surgical success and improves visual prognosis.PMID:38041678 | DOI:10.1136/bjo-2023-324318 (Source: The British Journal of Ophthalmology)
Source: The British Journal of Ophthalmology - December 2, 2023 Category: Opthalmology Authors: Haixia Guo Jinguo Yu Tiangeng He Song Chen Zhuoyu Sun Jingkai Zhang Zhiyong Sun Wenhui Yang Baoqun Yao Xueli Yang Yuanyuan Liu Mingxue Zhang Yu Meng Likun Yang Hua Yan Source Type: research

Clinical Features and the Outcome Evaluations of Keloid and Hypertrophic Scar Treatment with Triamcinolone Injection in Mekong Delta, Vietnam - A Cross-Sectional Study
CONCLUSION: Triamcinolone intralesional injection should be utilized as a first-line therapy for hypertrophic scarring.PMID:38021426 | PMC:PMC10661894 | DOI:10.2147/CCID.S432735 (Source: Clinical, Cosmetic and Investigational Dermatology)
Source: Clinical, Cosmetic and Investigational Dermatology - November 29, 2023 Category: Dermatology Authors: Lam Van Nguyen Huy Quang Ly Hau Thi Vo Thao Thanh Pham Nam Ky Nguyen Thi Van Vo Trung Quoc Phan Phuong Thi Ngoc Tran Hung Huynh Vinh Ly Ha Thi Thao Mai Source Type: research

Nail lichen planus treatment safety
Expert Opin Drug Saf. 2023 Nov 28. doi: 10.1080/14740338.2023.2288902. Online ahead of print.ABSTRACTTopical therapies for nail lichen planus (clobetasol propionate, topical tacrolimus, bath-PUVA), intralesional treatment (triamcinolone), and systemic treatment (corticosteroids, retinoids, small molecule inhibitors (jak/stat inhibitors), TNF-alpha inhibitors (etanercept), systemic immunomodulators (oral calcineurin inhibitors, mycophenolate mophetil), and antimalarials (chloroquine), each with unique safety profiles and considerations. Herein, we discuss common and uncommon adverse events, as well as utilization for specia...
Source: Expert Opinion on Drug Safety - November 28, 2023 Category: Drugs & Pharmacology Authors: Eden N Axler Shari R Lipner Source Type: research

Nail lichen planus treatment safety
Expert Opin Drug Saf. 2023 Nov 28:1-12. doi: 10.1080/14740338.2023.2288902. Online ahead of print.ABSTRACTTopical therapies for nail lichen planus (clobetasol propionate, topical tacrolimus, bath-PUVA), intralesional treatment (triamcinolone), and systemic treatment (corticosteroids, retinoids, small molecule inhibitors (jak/stat inhibitors)), TNF-alpha inhibitors (etanercept), systemic immunomodulators (oral calcineurin inhibitors, mycophenolate mophetil), and antimalarials (chloroquine), each with unique safety profiles and considerations. Herein, we discuss common and uncommon adverse events, as well as utilization for ...
Source: Expert Opinion on Drug Safety - November 28, 2023 Category: Drugs & Pharmacology Authors: Eden N Axler Shari R Lipner Source Type: research

Effectiveness of single intra-bursal injection of platelet-rich plasma against corticosteroid under ultrasonography guidance for shoulder impingement syndrome: a randomized clinical trial
ConclusionPRP and triamcinolone in the SASD bursa could be considered as safe treatment options for SIS under ultrasonography guidance. While triamcinolone was effective in short-term pain reduction, PRP was effective in long-term improvement in shoulder abduction. (Source: Skeletal Radiology)
Source: Skeletal Radiology - November 20, 2023 Category: Radiology Source Type: research

Hypohidrotic Ectodermal Dysplasia Milia Treatment With Fractional Carbon Dioxide Laser and Laser-Assisted Drug Delivery of Triamcinolone
J Drugs Dermatol. 2023 Nov 1;22(11):1130-1132. doi: 10.36849/JDD.7650.ABSTRACTHypohidrotic ectodermal dysplasia (HED) is a genetic disorder characterized by hypohidrosis, hypodontia, and hypotrichosis. Skin manifestations, including dyspigmentation and milia-like papules that coalesce into plaques, are difficult to treat. There is no cure for HED, therefore treatment is focused on managing symptoms and improving quality of life. There is limited evidence in the literature for safe and effective treatments improving HED-related facial skin aesthetics. The facial skin rashes caused by HED demonstrate an unmet clinical need i...
Source: Journal of Drugs in Dermatology - November 9, 2023 Category: Dermatology Authors: Jessica Mineroff Jessica R Dowling Nicole M Golbari Todd Wechter Jared Jagdeo Source Type: research